Alternate methods to prevent protease use as a masking agent in sport

Journal of Science and Medicine in Sport

Volumn 13, Issue 5, 2010, Pages 473-474

  Sanchis Gomar, F ^a   Martinez Bello, V E ^a   Nascimento, A L ^a   Gomez Cabrera, M C ^a   Vina J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; ERYTHROPOIETIN; PAPAIN; RECOMBINANT ERYTHROPOIETIN; SUBTILISIN; TRYPSIN;

ALBUMINURIA; DOPING; EDITORIAL; PROTEIN URINE LEVEL; SPORTS MEDICINE; URINALYSIS;

EID: 77955656997     PISSN: 14402440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsams.2010.02.003     Document Type: Editorial

References (15)

1. WADA The 2010 prohibited list of substances international standard 2010, [1-11-2010]. http://www.wada-ama.org/.
2. Elliott S. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol 2008, 154:529-541.
3. Lamon S., Robinson N., Sottas P.E., Henry H., Kamber M., Mangin P., et al. Possible origins of undetectable EPO in urine samples. Clin Chim Acta 2007, 385:61-66.
4. Thevis M., Maurer J., Kohler M., Geyer H., Schänzer W. Proteases in doping control analysis. Int J Sports Med 2007, 28:545-549.
5. Thomas A., Kohler M., Walpurgis K., Schänzer W., Thevis M. Proteolysis and autolysis of proteases and the detection of degradation products in doping control. Drug Test Anal 2009, 1:81-86.
6. Tsivou M., Dimopoulou H.A., Leontiou I.P., Georgakopoulos D.G., Koupparis M.A., Atta-Politou J., et al. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin. Clin Chim Acta 2009.
7. de Jong P.E., Gansevoort R.T., Bakker S.J. Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?. J Nephrol 2007, 20:375-380.
8. Halimi J.M., Hadjadj S., Aboyans V., Allaert F.A., Artigou J.Y., Beaufils M., et al. Microalbuminuria and urinary albumin excretion: French clinical practice guidelines. Diabetes Metab 2007, 33:303-309.
9. Alvarez C., Mir J., Obaya S., Fragoso M. Hematuria and microalbuminuria after a 100 kilometer race. Am J Sports Med 1987, 15:609-611.
10. Beullens M., Delanghe J.R., Bollen M. False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood 2006, 107:4711-4713.
11. Moinuddin I., Leehey D.J. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis 2008, 15:83-96.
12. Poortmans J.R., Brauman H., Staroukine M., Verniory A., Decaestecker C., Leclercq R. Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans. Am J Physiol 1988, 254:F277-283.
13. Poortmans J.R., Labilloy D. The influence of work intensity on postexercise proteinuria. Eur J Appl Physiol Occup Physiol 1988, 57:260-263.
14. Lasne F., Martin L., Martin J.A., de Ceaurriz J. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control. Haematologica 2009, 94:888-890.
15. Barrett A.J., Rawlings R.D., Woessner J.F., Neil R.D. The handbook of proteolytic enzymes 2003, Academic Press, [ISBN 0-12r-r079610-4]. 2nd ed.